Metraipolis › archive › dc_3d82cbc583ea

Safety and immunogenicity of rVSVΔG-ZEBOV-GP vaccination when dosed concurrent with mRNA COVID-19 vaccine booster doses in healthy African adults (EbolaCov):… — Europe PMC PMID:40976661

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/40976661
DOI: 10.1136/bmjopen-2025-102898
License (as archived): solo-consultazione
Archived: 2026-11-09T20:10:06.176Z
SHA-256 of the archived text: 6e1de31965cae191e8aa24619b785beea354723b7c9d32e3d0dc33f4067b3e07
Stable URL of this page: https://metraipolis.com/documento/dc_3d82cbc583ea

How to cite

Safety and immunogenicity of rVSVΔG-ZEBOV-GP vaccination when dosed concurrent with mRNA COVID-19 vaccine booster doses in healthy African adults (EbolaCov):… — Europe PMC PMID:40976661 — Europe PMC (en), https://europepmc.org/article/MED/40976661 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_3d82cbc583ea (Metraipolis archive dc_3d82cbc583ea, sha256 6e1de31965cae191e8aa24619b785beea354723b7c9d32e3d0dc33f4067b3e07)

BibTeX

@misc{dc3d82cbc583ea,
  title = {Safety and immunogenicity of rVSVΔG-ZEBOV-GP vaccination when dosed concurrent with mRNA COVID-19 vaccine booster doses in healthy African adults (EbolaCov):… — Europe PMC PMID:40976661},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/40976661},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_3d82cbc583ea; sha256 6e1de31965cae191e8aa24619b785beea354723b7c9d32e3d0dc33f4067b3e07},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40976661. Agents can read the archived copy with the MCP tool read_document.